Larisa Ryvo
Impact in
-
- Cancer Treatment and Pharmacology
- Cancer Immunotherapy and Biomarkers
- Chemokine receptors and signaling
- HER2/EGFR in Cancer Research
-
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
- Oncology 9
- Cancer Treatment and Pharmacology 5
- HER2/EGFR in Cancer Research 2
- Lung Cancer Research Studies 1
- Cancer Immunotherapy and Biomarkers 1
-
- Advanced Breast Cancer Therapies 5
- Brain Metastases and Treatment 2
- Co-authors
- Marcelo Ehrlich (1 shared paper)Tsipi Meshel (1 shared paper)Moshe Inbar (2 shared papers)Leonor Leider–Trejo (1 shared paper)Iafa Keydar (1 shared paper)Gali Soria (1 shared paper)Sima Shina (1 shared paper)Alexander Shtabsky (1 shared paper)
- Journals
- Cancer Research (2 papers)Journal of Clinical Oncology (1 paper)Cytokine (1 paper)Integrative Cancer Therapies (1 paper)Clinical Breast Cancer (1 paper)
- Partner nations
- IsraelUnited StatesSpain
In The Last Decade
Larisa Ryvo
11 papers receiving 314 citations
Peers
Comparison fields: 5 of 49
- Oncology 193
- Immunology 69
- Cancer Research 45
- Pulmonary and Respiratory Medicine 62
- Pharmacology 20
Countries citing papers authored by Larisa Ryvo
This map shows the geographic impact of Larisa Ryvo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larisa Ryvo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larisa Ryvo more than expected).
Fields of papers citing papers by Larisa Ryvo
This network shows the impact of papers produced by Larisa Ryvo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larisa Ryvo. The network helps show where Larisa Ryvo may publish in the future.
Co-authors
The 25 scholars most cited alongside Larisa Ryvo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 78 | |
| 2 | 2013 | 61 | |
| 3 | 2017 | 55 | |
| 4 | 2018 | 36 | |
| 5 | 2017 | 34 | |
| 6 | 2021 | 18 | |
| 7 | 2006 | 15 | |
| 8 | 2017 | 11 | |
| 9 | 2015 | 6 | |
| 10 | 2021 | 2 | |
| 11 | 2017 | 1 | |
| 12 | 2021 | 0 | |
| 13 | Oncology Treatments during the COVID-19 Pandemic in Israel: the ONCOR Study. | 2021 | 0 |
About Larisa Ryvo
Larisa Ryvo is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Pharmacology and Genetics, having authored 13 papers that have together received 317 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Advanced Breast Cancer Therapies (5 papers), Immunotherapy and Immune Responses (2 papers), Brain Metastases and Treatment (2 papers), HER2/EGFR in Cancer Research (2 papers), Cell Adhesion Molecules Research (1 paper), Lung Cancer Research Studies (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Oncology (193 citations), Immunology (69 citations), Cancer Research (45 citations), Pulmonary and Respiratory Medicine (62 citations) and Pharmacology (20 citations). Larisa Ryvo has collaborated with scholars based in Israel, United States and Spain. Frequent co-authors include Marcelo Ehrlich, Tsipi Meshel, Moshe Inbar, Leonor Leider–Trejo, Iafa Keydar, Gali Soria, Sima Shina, Alexander Shtabsky, Neora Yaal‐Hahoshen and Adit Ben‐Baruch. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Cytokine, Integrative Cancer Therapies and Clinical Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.